Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/24 15:02 | 5/29/24 | EBS | Health | Drug | Pharmaceutical Preparations | Zoon Kathryn C | MD | D | S | -8 | 4.61 | 0 | -2 | -3 | 64 | D | |||||||||||||||
5/23/24 17:15 | 5/21/24 | EBS | Health | Drug | Pharmaceutical Preparations | Zoon Kathryn C | MD | D | S | -6 | 5.78 | 0 | -1 | -2 | 49 | D | |||||||||||||||
7/24/23 08:28 | 5/25/23 | EBS | Health | Drug | Pharmaceutical Preparations | Zoon Kathryn C | MD | D | S.m | -30 | 8.36 | 0 | -4 | -7 | 50 | D | |||||||||||||||
11/29/22 15:26 | 11/25/22 | EBS | Health | Drug | Pharmaceutical Preparations | Richard Ronald | MD | D | S | -23 | 11.94 | 0 | -2 | -9 | 20 | D | |||||||||||||||
6/13/22 16:16 | 6/9/22 | EBS | Health | Drug | Pharmaceutical Preparations | Zoon Kathryn C | MD | D | S | -37 | 31.52 | 0 | -1 | -6 | 20 | D | |||||||||||||||
5/25/22 16:12 | 5/24/22 | EBS | Health | Drug | Pharmaceutical Preparations | Zoon Kathryn C | MD | D | S | -71 | 35.53 | 0 | -2 | -14 | 12 | D | |||||||||||||||
11/15/21 17:53 | 11/15/21 | EBS | Health | Drug | Pharmaceutical Preparations | Lindahl Richard S | MD | O | EVP,CFO | P | 112 | 37.46 | 0 | 3 | 8 | 40 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |